Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

PDUFA V 'Program' First-Cycle Approval Rates Significantly Higher For All Applications

Dec 13 2016

• By Sue Sutter

FDA entrance sign 2016

Related Content

PDUFA V Reviews Are ‘Best Ever’ For Some Sponsors, Maybe Not FDA

Apr 06 2015

Biosimilars Will Get PDUFA-Style Reviews Under New User Fee Plan

Sep 28 2016

“Breakthrough” Review: FDA And Sponsors Discuss Ways To Improve Efficiency

May 12 2014

Sponsors, FDA Reviewers To Get More Flexibility Under New User Fee Program

Jul 16 2016

PDUFA V ‘Program’ Gets Positive Evaluation – Except For Inspections

Apr 02 2015

FDA ‘Expedited Review’ Would Shave Off Additional Month For Some ‘Breakthrough’ Products

Mar 10 2015

FDA Review “Program” Tweaks May Include Smaller Mid-Cycle Meetings

Jun 30 2014

Additional Topics

United States Policy Drug Review FDA BioPharmaceutical

More from Product Reviews

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window